ライフサイエンスコーパス: chemokine receptor

1 sidues are affected by interactions with the chemokine receptor.

2 nce for epigenetic regulation of an atypical chemokine receptor.

3 nts is enforced by the ordered expression of chemokine receptors.

4 ies and challenges to find novel ligands for chemokine receptors.

5 spleen and lung cells expressing CCR3/CCR10 chemokine receptors.

6 aves the way for future allosteric drugs for chemokine receptors.

7 at CCR9, but potentially extending to other chemokine receptors.

8 s the plaque progression and upregulation of chemokine receptors.

9 occupancy as a key parameter when targeting chemokine receptors.

10 t rs2814778(G) of the gene encoding atypical chemokine receptor 1 (ACKR1).

11 cells expressing its receptor, the chemerin chemokine receptor 1 (CMKLR1), to sites of tumor.

12 Ep3 deficiency diminishes CX3C chemokine receptor 1 (CX3CR1) expression and vascular en

13 n vasculature where they reside through CX3C-chemokine receptor 1 (CX3CR1)-dependent adherence.

14 p130, CCL4, TNFalpha, SH2D1B, CAV1, atypical chemokine receptor 1 [duffy blood group]) whose mRNA tra

15 re recombinase under the control of the CX3C chemokine receptor 1 promoter.

16 Atypical chemokine receptor 2 (ACKR2) binds and scavenges proinfl

17 membrane-bound psoriasis-associated atypical chemokine receptor 2 (ACKR2) binds, internalizes and deg

18 Chemokine receptor 2 (CCR2(+)) monocytes invade the hipp

19 CC Chemokine Receptor 2 (CCR2) and its endogenous ligand CC

20 Chemokine receptor 2 (CCR2) expression and responsivenes

21 CC chemokine receptor 2 (CCR2) is one of 19 members of the

22 mation through activation of endothelial CXC Chemokine Receptor 2 (CXCR2) and production of endotheli

23 We also found that neither CXC chemokine receptor 2 (CXCR2) nor interleukin-17 (IL-17)

24 lymphotoxin-beta receptor (LTbetaR) and CXC chemokine receptor 2 (CXCR2), is involved in type B EAE

25 Compared with MMR- and C-C chemokine receptor 2-deficient mice, significantly highe

26 rapidly mobilized upon inflammation in a CC-chemokine receptor 2-dependent manner, and the nonclassi

27 cytes, and this process to require C-C motif chemokine receptor 2.

28 ltrate by modulating the expression of C-X-C chemokine receptors 2 and 4 on peripheral blood neutroph

29 The atypical chemokine receptor 3 (ACKR3) binds chemokines CXCL11 and

30 The CXC chemokine ligand 10 (CXCL10)/CXC chemokine receptor 3 (CXCR3) chemokine pathway promotes

31 The G protein-coupled receptor (GPCR) C-X-C chemokine receptor 3 (CXCR3) is a potential drug target

32 tion to IL-17A, the chemokine receptor C-X-C chemokine receptor 3 (CXCR3) is also important to enable

33 d abolished their differentiation into C-X-C chemokine receptor 3 (CXCR3)(lo)CD43(lo) effector-like m

34 Lymphocytes expressing C-X-C chemokine receptor 3 CD8 significantly correlated with O

35 environment signals in cancer: (C-X-C motif) chemokine receptor 4 (CXCR4) and PTK2 (encoding for foca

36 We identify CXC chemokine receptor 4 (CXCR4) as a receptor used by amine

37 C-X-C chemokine ligand 12 (CXCL12) and C-X-C chemokine receptor 4 (CXCR4) in orthotopic murine CRC mo

38 Chemokine receptor 4 (CXCR4) is a key factor for tumor g

39 The G protein-coupled protein receptor C-X-C chemokine receptor 4 (CXCR4) is an attractive target for

40 ve hypoxia-induced expression of C-X-C motif chemokine receptor 4 (CXCR4) on invading tumor cells, ma

41 hat three genes belonging to the C-X-C motif chemokine receptor 4 (CXCR4) pathway were downregulated

42 The CXC-motif chemokine receptor 4 (CXCR4) represents a promising targ

43 Internalization of C-X-C chemokine receptor 4 (CXCR4), but not CXCR5, was affecte

44 The chemokine receptor, CXC chemokine receptor 4 (CXCR4), is selective for CXC chemo

45 ns covering all 352 residues of the GPCR CXC chemokine receptor 4 (CXCR4), we identified 41 amino aci

46 migration assays and by blocking C-X-C motif chemokine receptor 4 (CXCR4).

47 stromal cell-derived factor-1 (SDF-1)/C-X-C chemokine receptor 4 axis, in the development of those l

48 the lungs to up-regulate CXCR4 (C-X-C motif chemokine receptor 4) before entering the bone marrow, w

49 We identify Wnt-Cxcr4 (chemokine receptor 4) signaling in regulation of OPC-end

50 immunodeficiency virus (HIV) and human C-X-C chemokine receptor-4 (CXCR4) facilitates migration of in

51 T-cell expression levels of CC chemokine receptor 5 (CCR5) are a critical determinant o

52 evaluated whether the disruption of the C-C chemokine receptor 5 (CCR5) locus in pigtailed macaque H

53 dified unselected CD8 T cells to express CXC chemokine receptor 5 (CXCR5), the chemokine receptor imp

54 autoimmune encephalomyelitis (EAE), the C-C chemokine receptor 6 (CCR6) is critical for pathogenic T

55 Chemokine ligand 8 (P = 0.04) and chemokine receptor 6 (P = 0.004) were up-regulated in bi

56 L17A, IL17F, retinoid-orphan-receptor C, C-C chemokine receptor 6, and the IL23 receptor.

57 t, even when LN retention signals such as CC chemokine receptor 7 (CCR7) are down-regulated, T cell i

58 C-C chemokine receptor 7 (CCR7) facilitates entry of T cells

59 adipose tissue immune cells that express C-C chemokine receptor 7 (CCR7) in mice and humans, and that

60 vity induced by BRAFV600E inhibits C-C motif chemokine receptor 7 (CCR7)-mediated DC migration, trapp

61 chemoresistance by upregulating C-X-C motif chemokine receptor 7 (CXCR7) expression through signal t

62 The atypical C-X-C chemokine receptor 7 (CXCR7) has been implicated in supp

63 -regulation of SDF-1, and its receptor C-X-C chemokine receptor 7, was documented on podocytes and PE

64 Chemokine receptor 9 (CCR9), a cell surface chemokine re

65 CC chemokine receptor 9 (CCR9), which is a unique receptor

66 CCL19 and CCL21 also bind atypical chemokine receptor (ACKR) 4.

67 We further demonstrate that the atypical chemokine receptor ACKR2, which scavenges inflammatory C

68 The atypical chemokine receptor ACKR3 (formerly CXCR7), overexpressed

69 The atypical chemokine receptor ACKR3 contributes to chemotaxis by bi

70 d CCL21, which are scavenged by the atypical chemokine receptor ACKR4.

71 nal similarities with the family of atypical chemokine receptors (ACKRs).

72 ght a key role for cholesterol in modulating chemokine receptor activities.

73 xpression of immune-related pathways such as chemokine receptor activity, chemotaxis and cytokine bio

74 Dendritic cells (DCs) expressing the XCR1 chemokine receptor, also known as CD103(+) or CD8alpha(+

75 Differences in the chemokine receptor and beta1 integrin expression profile

76 luding elevated expression of chemokines and chemokine receptors and an oxidative response.

77 ty through the photoactivation of engineered chemokine receptors and calcium release-activated calciu

78 1alpha regulates the expression of important chemokine receptors and cell adhesion molecules that con

79 On the other hand, chemokine receptors and cytokines, usually induced in ac

80 major Th-cell subsets using combinations of chemokine receptors and fluorescence-activated cell sort

81 lesterol on the organization and function of chemokine receptors and GPCRs in general include direct

82 While several chemokine receptors and ligands control multiple stages

83 clones expressed high levels of skin-homing chemokine receptors and migrated in the presence of the

84 rresponding to the elevated concentration of chemokine receptors and more importantly increased PET s

85 ppears to be present in a large number of CC chemokine receptors and thereby could play a more genera

86 ine mediators are found to bind to classical chemokine receptors and to elicit critical biological re

87 -associated surface markers, interleukin-10, chemokine receptors, and immunoglobulin heavy-chain isot

88 This process is inhibited by chemokine receptor antagonists (CoRAs) that block Env-re

89 ified, but, to date, only two small molecule chemokine receptor antagonists have been approved by the

90 Moreover, different chemokine receptors are critical for C. trachomatis-spec

91 Chemokines and chemokine receptors are implicated in regulatory T cell

92 The superfamilies of chemokines and chemokine receptors are of major importance in guiding i

93 Chemokine receptors are seven transmembrane-domain recep

94 itiating cells (TICs), the tumor stroma, and chemokine receptors, as well as invasion and metastasis.

95 to its apparent inhibitory effects on CXCR4 chemokine receptor, autophagy, and cholesterol metabolis

96 s that is strongly affected by the chemokine-chemokine receptor axes regulating the trafficking of in

97 erapies and point to a multifaceted role for chemokine receptor binding in promoting HIV-1 entry.

98 FI-binding affinity and the stoichiometry of chemokine receptor binding to trimeric Env.

99 Our analysis suggests two distinct roles for chemokine receptor binding, one to trigger formation of

100 els on target cells or eliminating competent chemokine receptor-binding sites on Env trimers resulted

101 s and models promote unique understanding of chemokine receptor biology, including the interpretation

102 udies showed that in addition to IL-17A, the chemokine receptor C-X-C chemokine receptor 3 (CXCR3) is

103 lar, the content of T lymphocytes bearing CC chemokine receptor (CCR) 1, CCR3, and CCR5 receptors for

104 lencing of a group of chemokine (CC/CXC) and chemokine receptor (CCR) mRNAs, thereby helping to resol

105 IF-2alpha strongly induced expression of the chemokine receptor CCR1 in multiple myeloma PCs.

106 cular accumulation of T cells expressing the chemokine receptors CCR1, CCR3, and CCR5.

107 latory properties and high expression of the chemokine receptor CCR10 for localization into the skin.

108 cells caused by knockout of the skin-homing chemokine receptor CCR10 resulted in an altered balance

109 ent of CXCR3 or CXCR6, or the skin-selective chemokine receptors CCR10 and CCR8.

110 The CCL2 chemokine receptor CCR2 drives cancer by mediating the r

111 monocyte-derived macrophages, which use the chemokine receptor CCR2 to gain entry to injured tissues

112 identified two novel biased ligands for the chemokine receptors CCR2 and CCR5 and characterized thei

113 The chemokine receptors CCR2 and CX3CR1 play a major role in

114 The chemokine receptors CCR2, CCR5, and CX3CR1 coordinate mo

115 d, CD18, CD11a, CD11b, L-selectin) or of the chemokine receptor CCR3, but decreased CD49d and CCR3 wa

116 Elevated expression of the chemokine receptor CCR4 in tumors is associated with poo

117 In conclusion, our study suggested that chemokine receptor CCR4 promotes HCC malignancy and faci

118 Most of these lymphocytes express the chemokine receptor CCR4, and the frequency of blood CCR4

119 ated T cell recruitment to the heart via the chemokine receptor CCR5 by inducing autocrine CCR5 ligan

120 We investigated the role of chemokine receptor Ccr5 in a mouse model of TBEV infecti

121 ible and dependent on CCL5 signaling via the chemokine receptor, CCR5.

122 show that in mice, activated B cells use the chemokine receptor CCR6 to access the subepithelial dome

123 activated memory phenotype and expression of chemokine receptors CCR6 and CCR9.

124 The chemokine receptor CCR7 drives leukocyte migration into

125 icate that ABCs express higher levels of the chemokine receptor CCR7, have higher responsiveness to C

126 Their migration requires the chemokine receptor CCR7, which directs egress from the s

127 from brain parenchyma is dependent upon the chemokine receptor CCR7.

128 r X receptor (LXR)-mediated induction of the chemokine receptor CCR7.

129 -2) for ligand binding and activation in the chemokine receptor CCR8.

130 The chemokine receptor CCR9 controls the immigration of mult

131 pregulating the integrin alpha4beta7 and the chemokine receptor CCR9.

132 Fibronectin, C-C chemokine receptors (CCRs)2 and 7, and oxidative stress

133 ecific small molecule antagonist of the CCR6 chemokine receptor, CCX2553, was efficacious in reducing

134 Influx of MoMFs is dependent on the chemokine receptor, chemokine (C-C motif) receptor 2 (CC

135 has obscured the contributions of individual chemokine receptor/chemokine pairs to this process.

136 in melanoma microenvironment is supported by chemokine receptor/chemokine signaling.

137 oming involve chemokines (Ch) and lymphocyte chemokine receptors (ChR) for vascular wall arrest and d

138 okine and small molecule action, whereas the chemokine receptor conserved disulfide bridge between th

139 The metal ion Zn(2+) is anchored to the chemokine receptor-conserved Glu-283(VII:06/7.39) Both c

140 Here we show that CCR7, the central chemokine receptor controlling immune cell trafficking t

141 ligand discovery and design studies based on chemokine receptor crystal structures and homology model

142 ifferentially promoted the expression of the chemokine receptor CX3CR1 and the integrin alpha4beta7 o

143 Here, we found that the chemokine receptor CX3CR1 identifies three distinct CD8(

144 ders had a significantly lower expression of chemokine receptor CX3CR1 on CD56(bright) NK cells and i

145 The G protein-coupled chemokine receptor CX3CR1 plays a central role in severa

146 red strongly to the renal vascular wall in a chemokine receptor CX3CR1-dependent manner.

147 ity of intramuscular macrophages express the chemokine receptor CX3CR1.

148 tment and activation are orchestrated by the chemokine receptors CX3CR1 and CCR2 and their cognate li

149 ted mice expressed lower levels of F4/80 and chemokine receptors CX3CR1 and CCR2 in the F4/80(+) rena

150 ne.IMPORTANCE RSV binds to the corresponding chemokine receptor, CX3CR1, through a CX3C chemokine mot

151 he G protein, RSV binds to the corresponding chemokine receptor, CX3CR1.

152 The chemokine receptor, CXC chemokine receptor 4 (CXCR4), is

153 me cyclooxygenase-2, the IL-8 receptor C-X-C chemokine receptor (CXCR) 1, and the intracellular kinas

154 ukocytes after binding to its receptor C-X-C chemokine receptor (CXCR) 3.

155 of CXCL4 or pharmacologic inhibition of the chemokine receptor CXCR2, significantly decreased cell v

156 es through non-cognate interactions with the chemokine receptors CXCR2 and CXCR4, in addition to acti

157 ment with Ag downregulates expression of the chemokine receptor CXCR3 and prevents diabetogenic Th1 c

158 ort that Tregs expressing the TH1-associated chemokine receptor CXCR3 are enriched in the kidneys of

159 ty to downregulate Th1 responses by inducing chemokine receptor CXCR3 expression.

160 ration is due to a reduction in inflammatory chemokine receptor CXCR3 surface expression and cellular

161 Unexpectedly, however, the chemokine receptor CXCR3 was critical for T cell accumul

162 The chemokine receptor CXCR3 was identified in 1996, and nea

163 glycolysis activated upon engagement of the chemokine receptor CXCR3 with the chemokine CXCL10.

164 ent of the Treg subpopulation expressing the chemokine receptor CXCR3.

165 e receptor NK1.1, the integrin CD103 and the chemokine receptor CXCR3.

166 to porcine endothelium depends on particular chemokine receptors (CXCR3, CCR4) and integrins (CD18 an

167 lesions, and further, that the IFN-inducible chemokine receptor, CXCR3, is upregulated on alopecic ef

168 We found that two chemokine receptors, CXCR3 and CCR10, are upregulated on

169 The chemokine receptor CXCR4 and its chemokine ligand CXCL12

170 Interaction between the chemokine receptor CXCR4 and its chief ligand CXCL12 pla

171 r effectors of BM extravasation, such as the chemokine receptor CXCR4 and the integrin dimer VLA-4, b

172 The G-protein-coupled chemokine receptor CXCR4 generates signals that lead to

173 Conditional deletion of the chemokine receptor CXCR4 in MPPs reduced differentiation

174 Here, we report that the chemokine receptor CXCR4 is also found in proximity to t

175 The chemokine receptor CXCR4 mediates cell anchorage in the

176 in infection and inflammatory processes, the chemokine receptor CXCR4 might be a potent target in ima

177 s that focal adhesion kinase-1 (FAK) and the chemokine receptor CXCR4 promote epithelial repair mecha

178 tor S1PR5 on NK cells, and expression of the chemokine receptor CXCR4 were all required for NK cell l

179 n sites at the distal C-terminal tail of the chemokine receptor CXCR4, but were unable to determine w

180 , is caused by heterozygous mutations of the chemokine receptor CXCR4.

181 dhesion molecules (ICAM-1, MadCAM-1) and the chemokine receptor CXCR4.

182 ng integrins (CD11a/CD11c/CD29/CD49d/CD49e), chemokine receptors (CXCR4), and adhesion molecules (CD4

183 otoxic T cells (TC cells) that expressed the chemokine receptor CXCR5, selectively entered B cell fol

184 Atypical chemokine receptor CXCR7 (ACKR3) functions as a scavenge

185 The recently discovered chemokine receptor CXCR7 and its ligand stromal cell-der

186 The chemokine receptor CXCR7 is an attractive target for a v

187 Whereas the chemokine receptor CXCR7, expressed on PCECs, acts to pr

188 The atypical chemokine receptor D6/ACKR2 is expressed on apoptotic PM

189 eptor 1 (Trf1 or CD71) and the Duffy antigen/chemokine receptor (DARC or CD234).

190 the whole embryo from embryonic day 9.5 in a chemokine-receptor-dependent manner.

191 Atypical chemokine receptors do not mediate chemotaxis or G prote

192 Chemokines and chemokine receptors establish a complex network modulati

193 ocal recruitment of lymph node-resident XCR1 chemokine receptor-expressing DCs via secretion of the X

194 ytes using flow cytometry revealed increased chemokine receptor expression and enhanced transendothel

195 cule 1 (ICAM-1) expression in the brain, and chemokine receptor expression by both myeloid and T cell

196 rculating fibrocytes and characterized their chemokine receptor expression in 54 patients with COPD e

197 rization of MR1T cell clones showed multiple chemokine receptor expression profiles and secretion of

198 MSN-deficient T cells also displayed poor chemokine receptor expression, increased adhesion molecu

199 Of the chemokine receptor family, some specifically upregulated

200 rocytes highly expressed CXCR4 and CCR3, the chemokine receptors for CXCL12 and CCL11, respectively.

201 Nevertheless, a number of cytokine and chemokine receptor genes, most notably CCR8, were upregu

202 However, the diagnostic potential of these chemokine receptors has not been fully realized.

203 More than 40 chemokine ligands and 20 chemokine receptors have been identified, but, to date,

204 Chemokines and chemokine receptors have rapidly diversified in teleost

205 s to home to HSV lesions should elicit these chemokine receptors if possible to increase the homing o

206 xpress CXC chemokine receptor 5 (CXCR5), the chemokine receptor implicated in cellular entry into B-c

207 The most important chemokine receptor in mouse neutrophils is CXCR2, which

208 or sensitive and specific detection of these chemokine receptors in both a mouse vascular injury mode

209 CCR2 is the main chemokine receptor inducing macrophage and monocyte recr

210 novel difference between ATRA signaling and chemokine receptor induction in Treg versus Tconv and pr

211 he data identify similarities with classical chemokine-receptor interactions but also provide evidenc

212 Structure-function analysis of chemokine-receptor interactions reveals that CCL21 adopt

213 Studies indicate that the chemokine receptor is responsible for poor prognosis of

214 rative analysis of ligand binding pockets in chemokine receptors is presented, including a detailed d

215 a indicate that CX3CR1, a microglia-specific chemokine receptor, is a novel therapeutic target for en

216 subsets to bacterial survival, we challenged chemokine receptor knockout mice and found that P. gingi

217 For both FI classes, reducing chemokine receptor levels on target cells or eliminating

218 cilitates the prediction of the structure of chemokine receptor-ligand complexes that have not been c

219 n, greatly increased expression of the CXCR3 chemokine receptor ligands CXCL9 and CXCL10 in VV-infect

220 the structure-based discovery and design of chemokine receptor ligands.

221 MOSPD2 inhibited signaling events following chemokine receptor ligation.

222 Deletion of one allele of CX3CR1, a chemokine receptor, limited infiltration of peripheral i

223 f blasts from the CNS showed no evidence for chemokine receptor-mediated selective trafficking.

224 f antigen receptor-, cytokine receptor-, and chemokine receptor-mediated signaling was significantly

225 locyte colony-stimulating factor (G-CSF) and chemokine receptor-mediated signals.

226 the metabolic pathway serves as a target for chemokine receptor-mediated T cell tolerance and suppres

227 s the signaling events underlying Ag-induced chemokine receptor-mediated tolerance.

228 Cells expressing the corresponding cognate chemokine receptors migrate against this gradient by cra

229 e construction and application of structural chemokine receptor models for the elucidation of molecul

230 the elucidation of molecular determinants of chemokine receptor modulation and the structure-based di

231 Another set, comprising chemokine and chemokine receptor mRNAs, oscillates and resets at each

232 olipidemic recipients and those deficient in chemokine receptors necessary to recruit inflammatory Ly

233 ed high affinity synthetic agonists for this chemokine receptor, obtained by grafting the CXCL12 N-te

234 We emphasize the role of cholesterol in chemokine receptor oligomerization, thereby promoting th

235 g unselected CD8 T cells to express CXCR5, a chemokine receptor on TFH associated with B-cell follicl

236 interactions with seven-transmembrane (7TM) chemokine receptors on cell surfaces.

237 Although targeting of selected chemokine receptors on monocytes exhibited preclinical e

238 f T cells from the blood involves the use of chemokine receptors on the T-cell surface and chemokines

239 igated the effect of GCs on the gut-specific chemokine receptor pair, CCR9 and CCL25.

240 but the identification of a single specific chemokine/receptor pathway that may constitute a suitabl

241 ificant differential regulation of chemokine/chemokine receptor pathways, antigen processing componen

242 Chemokine receptors play important roles in the immune s

243 s revealed that CD26(high) cells have a rich chemokine receptor profile (including CCR2 and CCR5), pr

244 inhibitory receptors, reduced expression of chemokine receptors, proliferated less, and produced les

245 tic deletion of CX3CR1, a microglia-specific chemokine receptor, promotes recovery after traumatic sp

246 along with associated signals from Notch and chemokine receptors, regulates the beta-selection checkp

247 Interestingly, TKIs modulated the chemokine receptor repertoire of immune cells.

248 ss CXCR5 (C-X-C chemokine receptor type 5, a chemokine receptor required for homing to GCs) and expan

249 rsors to the lung was independent of CCR2, a chemokine receptor required for monocyte mobilization fr

250 chestrating cell migration, it is vital that chemokine receptor signaling is tightly regulated to ens

251 a show an additional layer of complexity for chemokine receptor signaling that might be exploited to

252 The kinetics of chemokine receptor signaling were disturbed, including c

253 terferon, M2 polarizing genes, and chemokine-chemokine receptor signaling were up-regulated in spleen

254 membrane bilayer, and consequently can tune chemokine receptor signaling.

255 mmation and identify Rgs1, and inhibition of chemokine receptor signalling as potential therapeutic t

256 trated upregulation of specific integrin and chemokine receptor signature suggesting interaction with

257 ) T cells exhibited diminished expression of chemokine receptors, specifically CCR4 and CXCR3, and th

258 In parallel, chemokine receptor structures with small molecules revea

259 eceptor 2 (CCR2) is one of 19 members of the chemokine receptor subfamily of human class A G-protein-

260 to migrate to the periphery via a variety of chemokine receptors such as CCR4, CCR5, and CCR7 and to

261 Lymphocyte trafficking via chemokine receptors such as CCR5 plays a critical role i

262 e type of inflammation, making the chemokine/chemokine receptor system a key point of the immune resp

263 The chemokine receptor-targeted (64)Cu-vMIP-II-comb showed e

264 ymphocytes in the circulation and is the key chemokine receptor that enables these cells to target th

265 CXCR4 is a chemokine receptor that is overexpressed in various huma

266 We review the chemokines and chemokine receptors that are important in asthma, food a

267 of BCL6 and BLIMP1 and unique expression of chemokine receptors that direct migration to inflamed si

268 lease promotes cross-talk between opioid and chemokine receptors that in part leads to reduced effica

269 form for sensitive and specific detection of chemokine receptors to assess plaque progression in mous

270 is linked with increased expression of other chemokine receptors to form Th1-, Th2-, and Th17-like Tf

271 recruits tumor cells expressing the cognate chemokine receptors to lymphatic vessels and LEC permeab

272 broad-spectrum peptide antagonist imaging 8 chemokine receptors together, the purpose of this study

273 -C chemokine receptor type 4 (CXCR4) and C-C chemokine receptor type 1 (CCR1), which are the receptor

274 Upstream to Fyn, MCP1 stimulated C-C chemokine receptor type 2 (CCR2) and Gi/o and inhibition

275 burned patients with a special focus on C-C chemokine receptor type 2 (CCR2) expressions on classica

276 C-C chemokine receptor type 2 (CCR2) is expressed by active

277 c ablation or pharmacologic inhibition of CC chemokine receptor type 2 (CCR2) reduced macrophage (MP)

278 ether CCX140-B, a selective inhibitor of C-C chemokine receptor type 2 (CCR2), could further reduce a

279 The generated MDSC were expressed C-C chemokine receptor type 2 (CCR2), which was enhanced by

280 Purpose To characterize a chemokine receptor type 2 (CCR2)-binding peptide adapted

281 A C-C chemokine receptor type 2 (CCR2)-positive macrophage sub

282 ng factor 1 receptor blockade diminished C-C chemokine receptor type 2 [CCR2(neg) (Ly6C(lo))] monocyt

283 ajor histocompatibility complex II/C-C motif chemokine receptor type 2) macrophages expressed higher

284 ons were impaired by the inhibitors of C-X-C chemokine receptor type 4 (CXCR4) and C-C chemokine rece

285 in collagen and elastin staining, and C-X-C chemokine receptor type 4, nuclear factor kappa beta, an

286 udies demonstrated that ORM1 can bind to C-C chemokine receptor type 5 (CCR5) on muscle cells and del

287 t T-cell population is enriched with a C-X-C chemokine receptor type 5 (CXCR5)(+)CD4(+) TFH precursor

288 r of differentiation 4 (CD4) and coreceptors chemokine receptor type 5 and chemokine-related receptor

289 V)-specific CD8 T cells express CXCR5 (C-X-C chemokine receptor type 5, a chemokine receptor required

290 CC chemokine receptor type 9 (CCR9) activation by CCL25 pla

291 that promote its interaction with one of the chemokine receptors, usually CCR5, ultimately leading to

292 CCR5 is the primary chemokine receptor utilized by HIV to infect leukocytes,

293 No chemokine receptor variant was associated with CAD, MI,

294 of several candidate skin-homing-associated chemokine receptors was measured using flow cytometry.

295 detailed analysis of activation markers and chemokine receptors was performed on IgG4-expressing B c

296 Chemokines receptors were profiled to search for the acc

297 Chemokine receptor 9 (CCR9), a cell surface chemokine receptor which belongs to the G protein-couple

298 cluding molecules such as ACKR2, an atypical chemokine receptor whose role in psoriasiform dermatitis

299 integration of new structural information on chemokine receptors with extensive structure-activity re

300 ation for modeling molecular interactions of chemokine receptors with small-molecule ligands, peptide